|
at 05:05 |
|
|
Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Dale Levitzke as CEO with immediate effect, as Dr. Frank F. Craig, current CEO and co-founder,...
|
|
at 05:05 |
|
|
Scenic Biotech, a pioneer in the field of modifier therapies for severe genetic disorders, today announced that it has entered into a research collaboration with Bristol Myers Squibb to accelerate the development of Bristol Myers Squibb's drug...
|
|
at 05:00 |
|
|
As PetSafe® continues to lead the way in pet-tech innovations, we are proud to introduce the next evolution in pet fountains: the PetSafe® Outlasttm 90 oz Pumpless Pet Fountain with patented HydroSpintm technology....
|
|
at 05:00 |
|
|
BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany. The main objective of the project is to develop novel immunotherapeutic strategies to...
|
|
at 04:52 |
|
|
Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020 in Australia.
The Phase 1 clinical trial is a randomized, double-blind, placebo-controlled,...
|
|
at 04:09 |
|
|
A news report from China Daily:
The 2024 ZGC Forum in Beijing showcased a wide range of latest technological innovations.
The event ran from April 25 to 29 and comprised 128 activities, including forums and conferences, technology exchanges,...
|
|
|
